本页面由Tiger Trade Technology Pte. Ltd.提供服务

PMV Pharmaceuticals

1.41
-0.1100-7.24%
成交量:39.86万
成交额:57.27万
市值:1.06亿
市盈率:-1.00
高:1.55
开:1.55
低:1.40
收:1.52
52周最高:1.91
52周最低:1.02
股本:7,551.31万
流通股本:6,114.37万
量比:0.53
换手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-1.4131
每股收益(LYR):-1.4800
净资产收益率:-70.93%
总资产收益率:-42.39%
市净率:1.49
市盈率(LYR):-0.95

数据加载中...

2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/10

重要事件披露

8-K - Current report
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/28

重要事件披露

8-K - Current report
2023/03/01

重要事件披露

8-K - Current report
2023/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/04

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report